Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank64
5Y CAGR-27.3%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
-27.3%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202514.40%
20247.08%
202384.33%
2022-86.62%
2021-327.93%
202071.12%
2019-362.97%
201854.74%
201720.13%
2016-264.87%